Global Gene Corp CSO Saumya Jamuar appointed to head major new Genomic Medicine Centre in Singapore
September 23, 2019
Saumya Jamuar
Dr Saumya Jamuar

Global Gene Corp is proud to announce that co-Founder and co-Chief Scientific Officer Dr Saumya Jamuar has been appointed Head of the new SingHealth Duke-NUS Genomic Medicine Centre in Singapore. The centre has been created to meet the growing clinical demands of genomic medicine in the country and foster innovation in this fast-growing field.

Genomic medicine offers the opportunity to tailor treatment or prevention strategies according to the genetic makeup of each individual person, providing a personalised approach to tests and treatments can improve health outcomes, extend healthy lifespan and reduce healthcare costs.

As genomics enters mainstream clinical medicine, influencing healthcare delivery across all specialties, the newly founded centre will support these specialties in incorporating genomic services in their existing workflows, not only in the clinical but also research and education domains.

Dr Jamuar is a strong advocate for using genetic and genomic information to improve patient care and clinical outcomes and will be leading a multidisciplinary Centre providing integrated care and pushing the frontiers of clinical delivery, education and research.

Currently a Senior Consultant in the Genetics Service at KK Women’s and Children’s Hospital and Deputy Director of the SingHealth Duke-NUS Institute of Precision Medicine (PRISM), Dr Jamuar’s personal research interests include genetic disorders, precision medicine and neurodevelopmental disorders.

He took up his position at the Genomic Medicine Centre on  1st May, driving forward a vision focused on leveraging rapid advances in genomic technology to improve health outcomes for patients.

Dr Jamuar co-founded Global Gene Corp in 2013, together with his brother Sumit, Harvard Medical School geneticist Dr Jonathan Picker and corporate strategist Kushagra Sharma to address the lack of diversity in genomic datasets and bring the benefits of personalised healthcare to everyone, everywhere.

About Dr Saumya Jamuar

Dr Saumya Jamuar is co-founder and co-Chief Scientific Officer of Global Gene Corp. He completed his Genetics Fellowship and postdoctoral research at Harvard Medical School and remains a Visiting Scientist at the School. He is a Senior Consultant in the Genetics Service at KK Women’s and Children’s Hospital and Deputy Director of the SingHealth Duke-NUS Institute of Precision Medicine (PRISM), and PI and Clinical Lead, Singapore Undiagnosed Disease Programme.

He has published in top tier journals including the New England Journal of Medicine and Nature Genetics and is an international keynote speaker on the challenge and promise of harnessing diverse genomic insights for precision medicine.

About Global Gene Corp

Global Gene Corp a genomics data, insights and applications company with a vision to democratise healthcare through genomics. The company generates and analyses data from genetically diverse populations all over the world, including India and Africa, providing vital insights for developing precision healthcare approaches that are more likely to work for each individual person, no matter where they live or where they come from.

Based at the Wellcome Genome Campus in Hinxton, Cambridge UK, with offices in Boston, Singapore and India, Global Gene Corp works with stakeholders in the healthcare ecosystem and has partnerships with over 51 leading global healthcare and genomics institutions.

Follow us on Twitter @globalgenecorp  for insights into the #globalgenome